ATE312606T1 - Verwendung eines imidazolderivats zur behandlung oder verhütung von hypotension und schock - Google Patents

Verwendung eines imidazolderivats zur behandlung oder verhütung von hypotension und schock

Info

Publication number
ATE312606T1
ATE312606T1 AT00972934T AT00972934T ATE312606T1 AT E312606 T1 ATE312606 T1 AT E312606T1 AT 00972934 T AT00972934 T AT 00972934T AT 00972934 T AT00972934 T AT 00972934T AT E312606 T1 ATE312606 T1 AT E312606T1
Authority
AT
Austria
Prior art keywords
imidazole derivative
shock
treat
hypotension
prevent hypotension
Prior art date
Application number
AT00972934T
Other languages
English (en)
Inventor
Riitta Heino
Tiina Leino
Tarja Lehtimaeki
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Application granted granted Critical
Publication of ATE312606T1 publication Critical patent/ATE312606T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT00972934T 1999-10-29 2000-10-27 Verwendung eines imidazolderivats zur behandlung oder verhütung von hypotension und schock ATE312606T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16212099P 1999-10-29 1999-10-29
PCT/FI2000/000935 WO2001030347A1 (en) 1999-10-29 2000-10-27 Treatment or prevention of hypotension and shock

Publications (1)

Publication Number Publication Date
ATE312606T1 true ATE312606T1 (de) 2005-12-15

Family

ID=22584242

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00972934T ATE312606T1 (de) 1999-10-29 2000-10-27 Verwendung eines imidazolderivats zur behandlung oder verhütung von hypotension und schock

Country Status (11)

Country Link
US (4) US20070185181A1 (de)
EP (1) EP1223931B1 (de)
JP (1) JP4741131B2 (de)
AT (1) ATE312606T1 (de)
AU (1) AU778522B2 (de)
CA (1) CA2388979C (de)
DE (1) DE60024855T2 (de)
NO (1) NO329889B1 (de)
NZ (1) NZ518447A (de)
RU (1) RU2259827C2 (de)
WO (1) WO2001030347A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20022159A0 (fi) * 2002-12-05 2002-12-05 Orion Corp Uusia farmaseuttisia yhdisteitä

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2542738A1 (fr) * 1983-03-18 1984-09-21 Synthelabo Indanyl-2 d2-imidazoline, procede pour la preparer, et compositions pharmaceutiques qui la contiennent
GB2206880B (en) 1987-07-16 1991-04-24 Farmos Oy Optical isomers of an imidazole derivative
US5124157A (en) 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
FI894911A0 (fi) 1989-10-17 1989-10-17 Farmos Oy En terapeutiskt vaerdefull foerening.
FR2656610B1 (fr) * 1989-12-29 1992-05-07 Sanofi Sa Derives d'amino-2 phenyl-4 thiazole, leur procede de preparation et leur application therapeutique.
ATE376850T1 (de) * 1990-12-05 2007-11-15 Gen Hospital Corp Vorrichtung zum behandeln einen lungengefässverengung und von asthma
US5571840A (en) * 1993-06-22 1996-11-05 The Regents Of The University Of Michigan Method for treating central nervous system ischemia
GB2281206A (en) 1993-08-25 1995-03-01 Orion Yhtymae Oy Use of dexmedetomidine
CN1077886C (zh) * 1993-10-21 2002-01-16 G·D·瑟尔公司 用作一氧化一氮合酶抑制剂的脒基衍生物
US5713907A (en) * 1995-07-20 1998-02-03 Endotex Interventional Systems, Inc. Apparatus and method for dilating a lumen and for inserting an intraluminal graft
GB9520150D0 (en) * 1995-10-03 1995-12-06 Orion Yhtymae Oy New imidazole derivatives
US20030077227A1 (en) 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20050281752A1 (en) 1997-10-01 2005-12-22 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
AR015744A1 (es) 1998-04-01 2001-05-16 Orion Corp Uso de dexmedetomidina para sedacion en terapia intensiva
US6716867B1 (en) 1998-04-01 2004-04-06 Orion Corporation Use of dexmedetomidine for ICU sedation
US7001609B1 (en) 1998-10-02 2006-02-21 Regents Of The University Of Minnesota Mucosal originated drug delivery systems and animal applications
US6582457B2 (en) 2001-02-15 2003-06-24 Radiant Medical, Inc. Method of controlling body temperature while reducing shivering
US20030022926A1 (en) 2001-05-07 2003-01-30 Lavand'homme Patricia Method for treating neuropathic pain and pharmaceutical preparation therefor
FR2834212B1 (fr) 2001-12-27 2004-07-09 Besins Int Belgique Utilisation d'une poudre a liberation immediate dans des compositions pharmaceutiques et nutraceutiques
IL147921A0 (en) 2002-01-31 2002-08-14 Abdulrazik Mohammad A method for treating central nervous system disorders by ocular dosing
WO2008003093A2 (en) 2006-06-29 2008-01-03 Questcor Pharmaceuticals, Inc. Pharmaceutical compositions and related methods of treatment

Also Published As

Publication number Publication date
EP1223931B1 (de) 2005-12-14
US8470862B2 (en) 2013-06-25
US9446025B2 (en) 2016-09-20
JP4741131B2 (ja) 2011-08-03
AU1149201A (en) 2001-05-08
US20110294862A1 (en) 2011-12-01
US9078883B2 (en) 2015-07-14
US20070185181A1 (en) 2007-08-09
US20160030392A1 (en) 2016-02-04
CA2388979C (en) 2010-09-14
NO329889B1 (no) 2011-01-17
NO20021920L (no) 2002-06-14
NO20021920D0 (no) 2002-04-23
US20140100257A1 (en) 2014-04-10
NZ518447A (en) 2004-10-29
JP2003527333A (ja) 2003-09-16
DE60024855D1 (de) 2006-01-19
EP1223931A1 (de) 2002-07-24
WO2001030347A1 (en) 2001-05-03
CA2388979A1 (en) 2001-05-03
AU778522B2 (en) 2004-12-09
RU2259827C2 (ru) 2005-09-10
DE60024855T2 (de) 2006-08-31

Similar Documents

Publication Publication Date Title
DE69924641D1 (de) Behandlung von asthma anhand von mek-inhibitoren
CY1109191T1 (el) Μια νεα χρηση της δεφεριπρονης
DK1373215T3 (da) Gelanamycinderivater egnet til behandling af cancer
CY1109242T1 (el) Θεραπευτικοι παραγοντες χρησιμοι για θεραπεια πονου
ATE361752T1 (de) Methoden zur prophylaxe und behandlung von schäden der wahrnehmungshärchenzellen und der cochlearen neuronen
NO20006604L (no) Fremgangsmåter og transdermale sammensetninger for lindring av smerte
ATE422357T1 (de) Verwendung von allopurinol zur behandlung von bluthochdruck
ATE424824T1 (de) Verfahren zur verhütung oder behandlung von herzarrhythmie
EA201000630A1 (ru) Применение бензоконденсированных гетероциклических сульфамидных производных для понижения уровней липидов в крови
EA200801731A1 (ru) Составы и способы лечения тробмоцитемии
DE69822626T8 (de) Verwendung eines nitroxids oder seiner prodrugs zur prophylaktischen und therapeutischen behandlung von krebs
DE59907195D1 (de) Verfahren zur behandlung von erkrankungen oder störungen des innenohrs
ATE297739T1 (de) Endothelin-antagonisten zur behandlung von herzversagen
NO984160D0 (no) Fremgangsmåte for behandling eller forebyggelse av interstitiell cystitt
ATE312606T1 (de) Verwendung eines imidazolderivats zur behandlung oder verhütung von hypotension und schock
DE69818809D1 (de) Verfahren zur behandlung von narbengewebe
DE60236927D1 (de) Suchtpraevention in der schmerzbehandlung mit gamma vinyl gaba
ATE268170T1 (de) Verwendung von bernsteisäure oder deren salze zur behandlung von insulinresistenz
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
DE602006020838D1 (de) Medikamente zur prävention oder behandlung von herzversagen mit einem anticholinergikum
TR200103526T2 (tr) Kardiyovaskular hastalıkların terapisi için aminotetralin türevi.
NO984196D0 (no) Fremgangsmåte for behandling av stoffmisbruk
DE69635282D1 (de) Behandlung der exzessiven aggressivität mit olanzapine
TR200100670T2 (tr) R(+)-alfa-(2,3-Dimetoksifenil)-1- [2-(4-florofenil)etil]-4-piperidinmetanol' ün uyku düzensizlikleri tedavisinde kullanımı.
WO2001041703A3 (en) Method for treating allergic diseases

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties